相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Nonepithelial mineralocorticoid receptor activation as a determinant of kidney disease
Toshifumi Nakamura et al.
Kidney International Supplements (2022)
Testing for Primary Aldosteronism and Mineralocorticoid Receptor Antagonist Use Among US Veterans A Retrospective Cohort Study
Jordana B. Cohen et al.
ANNALS OF INTERNAL MEDICINE (2021)
Linking Kidney and Cardiovascular Complications in Diabetes-Impact on Prognostication and Treatment: The 2019 Edwin Bierman Award Lecture
Peter Rossing et al.
DIABETES (2021)
Deletion of Myeloid Interferon Regulatory Factor 4 (Irf4) in Mouse Model Protects against Kidney Fibrosis after Ischemic Injury by Decreased Macrophage Recruitment and Activation
Kensuke Sasaki et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2021)
Stabilization of hypoxia-inducible factor ameliorates glomerular injury sensitization after tubulointerstitial injury
Jun Zou et al.
KIDNEY INTERNATIONAL (2021)
Dapagliflozin in HFrEF Patients Treated With Mineralocorticoid Receptor Antagonists An Analysis of DAPA-HF
Li Shen et al.
JACC-HEART FAILURE (2021)
Activation of Rac1-Mineralocorticoid Receptor Pathway Contributes to Renal Injury in Salt-Loaded db/db Mice
Daigoro Hirohama et al.
HYPERTENSION (2021)
Role of mineralocorticoid receptor antagonists in kidney diseases
Vishal Patel et al.
DRUG DEVELOPMENT RESEARCH (2021)
Decoding myofibroblast origins in human kidney fibrosis
Christoph Kuppe et al.
NATURE (2021)
Screening Rates for Primary Aldosteronism in Resistant Hypertension
Gilad Jaffe et al.
HYPERTENSION (2020)
Acute kidney injury and maladaptive tubular repair leading to renal fibrosis
Samuel M. -W. Yu et al.
CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION (2020)
Cell profiling of mouse acute kidney injury reveals conserved cellular responses to injury
Yuhei Kirita et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2020)
Macrophage polarization in innate immune responses contributing to pathogenesis of chronic kidney disease
Hewang Lee et al.
BMC NEPHROLOGY (2020)
Effect of Finerenone on Chronic Kidney Disease Outcomes in Type 2 Diabetes
George L. Bakris et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Targeting PAI-1 in Cardiovascular Disease: Structural Insights Into PAI-1 Functionality and Inhibition
Machteld Sillen et al.
FRONTIERS IN CARDIOVASCULAR MEDICINE (2020)
Fibroblast-specific plasminogen activator inhibitor-1 depletion ameliorates renal interstitial fibrosis after unilateral ureteral obstruction
Lan Yao et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2019)
RAAS inhibitors directly reduce diabetes-induced renal fibrosis via growth factor inhibition
Sandor Koszegi et al.
JOURNAL OF PHYSIOLOGY-LONDON (2019)
The myeloid mineralocorticoid receptor controls inflammatory and fibrotic responses after renal injury via macrophage interleukin-4 receptor signaling
Jonatan Barrera-Chimal et al.
KIDNEY INTERNATIONAL (2018)
ANGIOTENSIN II SIGNAL TRANSDUCTION: AN UPDATE ON MECHANISMS OF PHYSIOLOGY AND PATHOPHYSIOLOGY
Steven J. Forrester et al.
PHYSIOLOGICAL REVIEWS (2018)
TGF-β promotes fibrosis after severe acute kidney injury by enhancing renal macrophage infiltration
Sungjin Chung et al.
JCI INSIGHT (2018)
Blocking TGF-β and β-Catenin Epithelial Crosstalk Exacerbates CKD
Stellor Nlandu-Khodo et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2017)
Tubulointerstitial fibrosis can sensitize the kidney to subsequent glomerular injury
Beom Jin Lim et al.
KIDNEY INTERNATIONAL (2017)
PAI-1 is a critical regulator of FGF23 homeostasis
Mesut Eren et al.
SCIENCE ADVANCES (2017)
The Spectrum of Subclinical Primary Aldosteronism and Incident Hypertension A Cohort Study
Jenifer M. Brown et al.
ANNALS OF INTERNAL MEDICINE (2017)
2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure
Piotr Ponikowski et al.
EUROPEAN HEART JOURNAL (2016)
PATHWAY-2: spironolactone for resistant hypertension Reply
Bryan Williams et al.
LANCET (2016)
TGF-β: the master regulator of fibrosis
Xiao-ming Meng et al.
NATURE REVIEWS NEPHROLOGY (2016)
Effect of mineralocorticoid receptor antagonists on proteinuria and progression of chronic kidney disease: a systematic review and meta-analysis
Gemma Currie et al.
BMC NEPHROLOGY (2016)
Aldosterone Induces Renal Fibrosis and Inflammatory M1-Macrophage Subtype via Mineralocorticoid Receptor in Rats
Beatriz Martin-Fernandez et al.
PLOS ONE (2016)
Therapeutic targeting of aldosterone: a novel approach to the treatment of glomerular disease
Andrew S. Brem et al.
CLINICAL SCIENCE (2015)
Effect of Finerenone on Albuminuria in Patients With Diabetic Nephropathy A Randomized Clinical Trial
George L. Bakris et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2015)
GM-CSF Promotes Macrophage Alternative Activation after Renal Ischemia/Reperfusion Injury
Sarah C. Huen et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2015)
Contribution of aldosterone to cardiovascular and renal inflammation and fibrosis
Nancy J. Brown
NATURE REVIEWS NEPHROLOGY (2013)
Renal interstitial fibrosis: mechanisms and evaluation
Alton B. Farris et al.
CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION (2012)
Aldosterone deficiency and mineralocorticoid receptor antagonism prevent angiotensin II-induced cardiac, renal, and vascular injury
James M. Luther et al.
KIDNEY INTERNATIONAL (2012)
Aldosterone-Induced Fibrosis in the Kidney: Questions and Controversies
Andrew S. Brem et al.
AMERICAN JOURNAL OF KIDNEY DISEASES (2011)
Aldosterone/NaCl-induced renal and cardiac fibrosis is modulated by TGF-β responsiveness of T cells
Barbara Schreier et al.
HYPERTENSION RESEARCH (2011)
Distinct Macrophage Phenotypes Contribute to Kidney Injury and Repair
Sik Lee et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2011)
Mineralocorticoid Receptors, Salt-Sensitive Hypertension, and Metabolic Syndrome
Toshiro Fujita
HYPERTENSION (2010)
Myeloid mineralocorticoid receptor controls macrophage polarization and cardiovascular hypertrophy and remodeling in mice
Michael G. Usher et al.
JOURNAL OF CLINICAL INVESTIGATION (2010)
Aldosterone Activates NF-kappa B in the Collecting Duct
Valerie Leroy et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2009)
Aldosterone antagonism or synthase inhibition reduces end-organ damage induced by treatment with angiotensin and high salt
William B. Lea et al.
KIDNEY INTERNATIONAL (2009)
Modification of mineralocorticoid receptor function by Rac1 GTPase: implication in proteinuric kidney disease
Shigeru Shibata et al.
NATURE MEDICINE (2008)
Aldosterone and TGF-β1 synergistically increase PAI-1 and decrease matrix degradation in rat renal mesangial and fibroblast cells
Wei Huang et al.
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY (2008)
Plasminogen activator inhibitor-1 deficiency protects against aldosterone-induced glomerular injury
J Ma et al.
KIDNEY INTERNATIONAL (2006)
Aldosterone synthase inhibitor ameliorates angiotensin II - Induced organ damage
A Fiebeler et al.
CIRCULATION (2005)
Aldosterone/salt induces renal inflammation and fibrosis in hypertensive rats
ER Blasi et al.
KIDNEY INTERNATIONAL (2003)
Transforming growth factor-beta in T-cell biology
L Gorelik et al.
NATURE REVIEWS IMMUNOLOGY (2002)
Aldosterone: A mediator of myocardial necrosis and renal arteriopathy
R Rocha et al.
ENDOCRINOLOGY (2000)
分享论文
